Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Does anyone remember the Slinky >? :)
Good Afternoon Everyone @ BillionaireBCMF :)
volume to start to pick up this week :)
Good Morning to "The Construction Stock of the Year" & News will come soon :)
Today is Super Monday The Last Trding Week of October 26 > 2005 :)
Good Morning Billionaire BCMF & Visitors :)
teapeebubbles >>>>>>>. Great reporting & thanks :)
It pays to advertisive =
"Residential hauling. All types of junk removed. No load too large or
too small. Garages, basements, addicts."
one mans junk is another mans gold
turn treasury into gold
anytime by appointment
Crow on the fence, rain will go hence. Crow on the ground, rain will come down.
On September 23, 1980, Big Thunder Mountain Railroad opened at Walt Disney World's Magic Kingdom in Orlando.
This year's autumnal equinox occurs on September 22 at 6:23 p.m. Eastern Daylight Time. It is said that the wind and weather at the time of the equinoxes foretells the wind and weather during the following three months. If the autumn is warm, it is reputed that the winter will be long. If there's much autumn fog, there will be much winter snow. If the autumn is clear, the winter will be windy. If the storms of September clear off warm, however, you can expect the winter storms to be relatively warm as well.
Winter a Coming
OIL > GAS > WOOD > :)
YOU WILL PAY more for these hardwoods, but you will get more heat for your dollar.
Ash, white
Beech
Birch, yellow
Hickory, shagbark
Hop hornbeam
Locust, black
Maple, sugar
Oak, red
Oak, white
Advice of the Day
It is bad luck to sweep trash out the door at night.
Today in History
Vasco Núñez de Balboa crossed Isthmus of Panama and sighted the Pacific Ocean, 1513
The use of our Cellphones in the Future it appears that the
possibilities are endless >
Downloading
Internet
Paying Bills
Tolls
The List Goes on & On
:)
Blond Update....
Two blonds living in Oklahoma were sitting on a bench talking........and one blond says to the other, "Which do you think is farther away..........Florida or the moon?" The other blond turns and says "Helloooooooooo!!! Can you see Florida.......?????"
Star's Purposes
I know that they are beautiful, but they provide very little light to Earth--not even enough to enable us to see. What purpose do the stars serve?
God used the stars as his witnesses. As you know, someday God will judge those who do not believe in the Lord Jesus Christ. However, in Deuteronomy 19:15, God Himself gave the law about judging others: One witness shall not rise up against a man for any iniquity, or for any sin, in any sin that he sinneth: at the mouth of two witnesses, or at the mouth of three witnesses, shall the matter be established. We know that God's Word will be one of three witnesses at the judgement of unbelievers, and that Jesus Christ will also be a witness. However the Bible states in Romans 1:20 that Creation has always been a witness for God: For the invisible things of him from the creation of the world are clearly seen, being understood by the things that are made, even his eternal power and Godhead; so that they are without excuse.
God also used the stars, the sun and the moon as His promise to David and the priests of Israel. Jeremiah 33:20-22 states...If ye can break my covenant of the day, and my covenant of the night, and that there should not be day and night in their season; then may also my covenant be broken with David my servant, that he should not have a son to reign upon his throne; and with the Levites the priests, my ministers. As the host of heaven cannot be numbered...so I will multiply the seed of David my servant, and the Levites that minister unto me. Of course, Jesus Christ is the son of David and sits upon the Heavenly throne. We believers are priests ministering to God.
The Bible also states that God set the stars in the heavens for several other purposes. One is to declare sermons of God. Psalm 19:1 states, The heavens declare the glory of God; and the firmament sheweth his handywork. Another purpose of the stars is to be signs. A sign in Scripture always points the way to God. The star of Bethlehem was a sign to the wise men leading them to Jesus Christ. Genesis 1:14 states, And God said, let their be lights in the firmament of the heaven to divide the day from the night; and let them be for signs, and for seasons, and for days, and years.
In addition, God created the stars to sing praises to Him. Psalm 148:1-4 states, Praise ye the Lord. Praise ye the Lord from the heavens: praise him in the heights. Praise ye him, all his angels: praise ye him, all his hosts. Praise ye him, sun and moon: praise him, all ye stars of light. Praise him, ye heaven of heavens, and ye waters that be above the heavens.
One reason that God uses the stars as helpers to witness for Him is that the stars are visible everywhere on Earth. According to Psalm 19:3-4, 'There is no speech nor language, where their voice is not heard. Their line is gone out through all the earth, and their words to the end of the world.'
Population, Linguistics, and History…
Population analyses estimate that the world population at the time of Christ was about 200 million. By 1650 the world’s population had increased to 500 million. In 1983 the world’s population reached 5 billion. Today there are 6.396 billion and are estimated to increase to 7.934 billion in 2025 and 9.276 billion in 2050. These figures show a growth rate of about .5% per year. More people will be alive when the Lord Jesus returns than have lived and died on Earth since the Flood.
If figured backward from the present day at .5% per year, population had its beginning with the eight people from the Ark about 4,500 years ago. Of course, the population growth rate today is 2% per year. Advancement in medicine, a decrease in death among newborns, and longer life spans in the 20th century account for this high rate. However, at times in history, the growth rate was less than .5% per year because of famines, diseases, and wars. Therefore .5% represents an average growth rate over the many centuries.
The Chinese characters in use until 1966 (when the Chinese reorganized their written language) were four thousand years old. The use of these particular characters came from ancient historical knowledge. The ancient Chinese character for boat is made up of three different characters that stand for vessel, eight, and people.
Another unusual character is the one that represents a flood. This character is composed of characters that represent eight (as in the word for boat), united, and earth. When these three characters are added to the character for water the character for flood is then formed. The characters united, earth and eight are characters for total when not attached to the character for water.
There are many different cultures having stories of a flood that covered the whole Earth. These Chinese words are certainly evidence that the Chinese knew of such an account. Their account agrees with the Biblical account that record eight people surviving the flood.
In fact, included in either the written or spoken histories of over two hundred cultures, is a record of a universal flood. American Indians, Chinese, Maoris, Eskimos, Lithuanians, and even people of Czechoslovakia tell old stories of a world-wide flood. People in ancient times, including the Egyptians, wrote down stories of a world-wide flood. Variations exist, but most of the flood stories include common major ideas.
A considerable number of these accounts record ten pre-Flood dynasties of kings. In each of these accounts, the names of these ten kings can be compared to the ten generations of the Genesis account from Adam to Noah. Each of these accounts states that the tenth king, who would be Noah or a king alive during Noah’s time, had his reign interrupted by a world-wide flood.
The Sumerian legend is the oldest non-Biblical account of the flood. It was written on clay tablets that were unearthed in north central Iraq. These tablets were written around 2000 B.C., perhaps four hundred years after the Flood. The Sumerians speak of God being angry with His people and sending a universal flood to destroy them. Both accounts tell of one man’s family that escaped by building a huge boat.
These amazingly similar stories could only originate from a common source and a single event that impressed the memory of all mankind.
‘In the beginning God created the heavens and the earth’ (Genesis 1:1). ‘And the waters prevailed exceedingly upon the earth, and all the high hills, that were under the whole heaven, were covered’ (Genesis 7:19).
People really believe what they want to believe. Because you want to be right with God, you find it easy to believe and accept the facts. A person who is not right with God must find reason, or justification, for not believing. So they accept an indefensible theory like evolutioneven if it will not hold water. That is the academic justification for unbelief. In fact, that is what all the many theories of evolution area mental justification for unbelief. If the unbeliever can accept a theory that leaves out God but can explain the origin of the universe, they can live as they please without being morally responsible to their Creator. Consequently, they are left to the discouragement of the realities of life and death, and they have no hope. The price of unbelief and moral inaccountability to God is discouragement, defeat, and purposelessness.
I’m glad we have God’s Word on which to build our faith. We have a risen Christ, unquestionable proofs, and, as if we needed it, God has thrown in a host of unarguable evidences all around us!
Octel Corp.
Global House
Bailey Lane
, M90 4AA
Phone: 44 16 1498 8889
Fax: 44 16 1498 1899
Web Site: http://www.octel-corp.com
Greetings & Welcome >
swan
GREENCAT
RIGATONI
eviltweety
Juststocks
Andy42o
Tee to Green
~ Susan ~
nocrappie
QuickTrade
Truman321
Fullmoon
Goodfill
ontheedge01
bkwheadon
stock_seeker
Farmboy273
wasatch
raniel
francal
:)
mick......thanks for posting the News Boards :)
Good Morning Billionaire BCMF & Today is Sunday The 25 of September 2005 :)
WYSK > About Wysak Petroleum
Wysak is a diversified energy company whose goal is to identify and develop traditional fossil fuel sites, as well as clean air alternative energy producing technologies.
Chart it :)
62794 = put a propeller on top of your roof = a Windmill & have the Electric Company buy back some of the Electric you use > :)
CYBX >
September 15, 2005 - 3:22 PM EDT
CYBX 31.71 0.16
Today 5d 1m 3m 1y 5y 10y
Cyberonics Clarifies Treatment-Resistant Depression (TRD) Third Party Payer Coverage Status and Plan
HOUSTON, Sept. 15 /PRNewswire-FirstCall/ -- In response to numerous investor inquiries, Cyberonics, Inc. (Nasdaq: CYBX) today clarified the status and its plan for third party insurance coverage for treatment-resistant depression.
'Cyberonics' FY06 TRD reimbursement mission and plan is to more quickly obtain favorable TRD coverage, coding and reimbursement to provide a greater percentage of Americans with TRD access to VNS Therapy following launch, than was the case in epilepsy,' commented Robert P. ('Skip') Cummins, Cyberonics' Chairman of the Board and Chief Executive Officer. 'Six weeks into our launch, we are not only ahead of schedule in terms coverage, coding and reimbursement, but we have significantly greater resources to accomplish our TRD objectives than we did in the first year after epilepsy launch. TRD coding and reimbursement are largely in place, more than two years ahead of the epilepsy case. As expected, our primary challenge and opportunity is to obtain favorable coverage decisions and policies.'
'Cyberonics today in TRD is ahead of where we were at the same time period following the epilepsy launch in terms of implementation of our reimbursement plan,' added Shawn P. Lunney, Vice President, Market Development. 'Over the past eight years since epilepsy approval, Cyberonics' reimbursement team has successfully pioneered entirely new coverage, coding and reimbursement for VNS that, much like VNS Therapy itself, has steadily improved for patients, physicians and hospitals over time. That coverage, coding and reimbursement has enabled over 30,000 Americans to be treated with VNS Therapy, and today provides essentially universal access to VNS for Americans with refractory epilepsy. In terms of favorable national coverage policies in epilepsy, we obtained a favorable Blue Cross Technology Evaluation Committee (TEC) evaluation approximately nine months after launch and favorable Medicare national coverage policy approximately two years after launch. Prior to obtaining those favorable national coverage policies for a revolutionary new therapy, we obtained case-by-case coverage approvals for almost 100% of the patients treated with VNS.
'Our goal in TRD is to beat our epilepsy precedent in terms of coverage and patient access,' continued Mr. Lunney. 'In terms of national coverage policy, there is apparently some confusion about the negative Blue Cross/Blue Shield TEC assessment from June 8, 2005 that was posted earlier this week on the TEC website. As expected, the June 2005 pre-approval assessment determined that VNS did not meet TEC criteria. The June 8, 2005 assessment was based solely on outdated, incomplete publicly-available information from the June 2004 FDA Advisory Panel Meeting that resulted in FDA's initial not-approvable decision and very few peer-revised publications. Not only did Cyberonics submit significantly more data to FDA after June 2004 that was instrumental in gaining FDA approval, but VNS was also approved, FDA's Summary of Safety and Effectiveness was finalized and four peer-reviewed publications confirming the safety and effectiveness of VNS in TRD appeared in Biological Psychiatry and the Journal of Clinical Psychiatry. None of these important data, findings and publications that confirm the safety and effectiveness of VNS Therapy and demonstrate that VNS now satisfies all the TEC criteria were available for the June TEC assessment. We expect to submit all this compelling 'new' information not available for the June 8 assessment to the TEC for re-assessment in the very near future to obtain a favorable assessment more quickly than we did in epilepsy. Included in our request for re-assessment, among a large number of references, will be the following statement from FDA's Summary of Safety and Effectiveness:
'In conclusion, CDRH believes the PMA applicant has provided reasonable
assurance of safety and efficacy based on valid scientific evidence as
required by statute and regulation for the approval of a Class III
medical device. CDRH has come to this conclusion because the sponsor has
provided data that were systematically collected and analyzed which
showed significant improvement from baseline over one and two years for a
definable subset of the target population, and comparative data against
a reasonably matched control which also sustained improvement over time.'
'Until such time as we obtain favorable national coverage policies, we will continue to obtain case-by-case prior authorizations and coverage for each TRD patient,' concluded Mr. Lunney. 'Cyberonics' case management team has already obtained a number of favorable case-by-case decisions from a variety of private and public payers including Blue Cross and Medicare. As compared to our epilepsy experience, we are much better equipped today to obtain such decisions in a timely manner for a larger number of patients considering that we today have 80 Case Managers supporting our TRD launch versus only two contractors from Health Technology Associates obtaining case- by-case coverage in the first year of epilepsy launch. In summary, Cyberonics reimbursement and case management teams remain confident that a greater percentage of patients with TRD will have access to VNS Therapy in the first year following launch on August 1, 2005 than was the case in the first year after epilepsy approval on July 16, 1997.'
'It is important to understand that Cyberonics' reimbursement plan and the assumptions in our sales guidance for FY06 are different,' added Pamela B. Westbrook, Vice President, Finance and Administration and Chief Financial Officer. 'Our sales guidance for FY06 assumes that a much lower percentage of TRD patients will be treated with VNS Therapy in the first year after launch than was the case in epilepsy. However, our reimbursement plan is to obtain favorable coverage, coding and reimbursement more quickly and thereby provide a greater percentage of TRD patients access to VNS.'
ABOUT DEPRESSION AND TREATMENT-RESISTANT DEPRESSION
Major Depressive Disorder (MDD) is one of the most prevalent and serious illnesses in the United States, affecting nearly 19 million Americans over the age of 18 in any given year. According to the National Institute of Mental Health, depression is the leading cause of disability in the United States and worldwide. Depression interferes with one's ability to function, feel pleasure or maintain interest in everyday living. MDD is associated with increased mortality due to suicide and comorbid general medical conditions including heart disease and stroke. Depressed patients use twice the healthcare services as non-depressed patients. Total annual costs of depression in the U.S. exceed $80 billion including $30 billion in annual direct treatment costs. A person with depression is 35 times more likely to commit suicide than a person not experiencing depression and 15 percent of previously hospitalized depressed patients commit suicide.
Most psychiatrists define treatment-resistant depression (TRD) as a major depressive episode that has not had an adequate response to two or more adequate antidepressant treatments at appropriate dose and duration. Twenty percent of those with depression or approximately four million people suffer from TRD. For these patients, treatments including psychotherapy, antidepressant medications and electroconvulsive therapy do not work. Studies show that annual healthcare costs for patients with TRD exceed $40,000 per patient per year, approximately six times the cost of those without TRD.
ABOUT VNS THERAPY AND CYBERONICS
Cyberonics, Inc. was founded in 1987 to design, develop and market medical devices for the long-term treatment of epilepsy, depression and other chronic treatment-resistant disorders using a unique therapy, vagus nerve stimulation (VNS). Stimulation is delivered by the VNS Therapy System(TM), an implantable generator similar to a cardiac pacemaker. The VNS Therapy System delivers preprogrammed intermittent mild electrical pulses to the vagus nerve in the patient's neck 24 hours a day. The Company's initial market was epilepsy, a disorder characterized by recurrent seizures. Epilepsy is the second most prevalent neurological disorder. The Cyberonics VNS Therapy System was approved by the FDA on July 16, 1997 for use as an adjunctive therapy in reducing the frequency of seizures in adults and adolescents over 12 years of age with partial onset seizures that are refractory to antiepileptic medications. The VNS Therapy System is also approved for sale as a treatment for epilepsy in all the European Economic Area, Canada, Australia and other markets. To date, more than 32,000 epilepsy patients in 24 countries have accumulated over 100,000 patient years of experience using VNS Therapy.
The VNS Therapy System was approved by the FDA on July 15, 2005 'as an adjunctive long-term treatment for chronic or recurrent depression for patients 18 years of age and older who are experiencing a major depressive episode and have not had an adequate response to four or more adequate antidepressant treatments.' As part of FDA's approval order, Cyberonics is required to conduct a 450- patient post-market dosing study and a 1,000-patient, five-year patient outcome registry. For more information on VNS Therapy for treatment-resistant depression, including the contraindications, warnings and precautions, see the Physician's and Patient's Manuals and other information at http://www.cyberonics.com or http://www.vnstherapy.com or call 1-877-NOW 4 VNS.
The VNS Therapy System has been approved for sale in the European Economic Area and in Canada as a treatment for depression in patients with treatment-resistant or treatment-intolerant major depressive episodes, including unipolar depression and bipolar disorder (manic depression) since 2001.
VNS Therapy is at various levels of investigational clinical study as a potential treatment for anxiety disorders, Alzheimer's disease, chronic headache/migraine and bulimia. The Company is headquartered in Houston, Texas and has an office in Brussels, Belgium. For additional information please visit us at http://www.cyberonics.com .
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These statements can be identified by the use of forward-looking terminology, including 'may,' 'believe,' 'will,' 'expect,' 'anticipate,' 'estimate,' 'plan,' 'intend,' and 'forecast,' or other similar words. Such forward-looking statements include statements concerning providing access to VNS Therapy for a greater percentage of patients with TRD in the first year following launch on August 1, 2005 than was the case in the first year after epilepsy approval on July 16, 1997 and submission of new data to the Blue Cross Blue Shield TEC in the near future to obtain a favorable assessment more quickly than we did in epilepsy. Statements contained in this press release are based upon information presently available to us and assumptions that we believe to be reasonable. We are not assuming any duty to update this information should those facts change or should we no longer believe the assumptions to be reasonable. Our actual results may differ materially. Important factors that may cause actual results to differ include, but are not limited to: continued market acceptance of VNS Therapy and sales of our product; the development and satisfactory completion of clinical trials and/or market test and/or regulatory approval of VNS Therapy for the treatment of Alzheimer's disease, anxiety, or other indications; adverse changes in coverage or reimbursement amounts by third-parties; intellectual property protection and potential infringement claims; maintaining compliance with government regulations and obtaining necessary government approvals for new applications; product liability claims and potential litigation; reliance on single suppliers and manufacturers for certain components; the accuracy of management's estimates of future expenses and sales; and other risks detailed from time to time in the Company's filings with the SEC.
SOURCE Cyberonics, Inc.
Source: PR Newswire (September 15, 2005 - 3:22 PM EDT)
News by QuoteMedia
www.quotemedia.com
& A Good Afternoon BBCMF :)
A passenger in a taxi leaned over to ask the driver
a question and tapped him on the shoulder. The driver
screamed, lost control of the cab, nearly hit a bus,
drove up over the curb, and stopped just inches from
a large plate glass window. For a few moments
everything was silent in the cab, and then the
still-shaking driver said, "I'm sorry but you scared
the daylights out of me." The frightened passenger
apologized to the driver and said he didn't realize a
mere tap on the shoulder could frighten him so much.
The driver replied, "No, no, I'm sorry, it's entirely
my fault. Today is my first day driving a cab....
I've been driving a hearse for the last 25 years."
CFGE > :)
From another post
GFCI >
Grifco, on the other hand, is actually claiming earnings:
http://www.marketwire.com/mw/release_html_b1?release_id=82071
With SiteWorks Inc we should be hearing Super News on several different projects that are in the Works...we have yet to near on the Wal-Mart project as to how it is coming along & then you have a New VP for Sales & Marketing and the there is the FLOOD > & ASIA and there should be GOVERNMENT Contracts a Coming too......the traveling will CONTINUE > over in Thailand & no telling where elso for other housing projects to be bid on as well >>>>>>>> FL & MS & LA are all States that will need work done & we all know that "SiteWorkds is the stock of year" will get some of the Contracts & news will come soon.
POCI > :)